Nkarta, Inc. (NKTX)
2.59
-0.07
(-2.63%)
USD |
NASDAQ |
Aug 24, 16:00
2.59
0.00 (0.00%)
After-Hours: 20:00
Nkarta Shareholders Equity (Quarterly) : 247.74M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 247.74M |
| March 31, 2026 | 285.86M |
| December 31, 2025 | 312.32M |
| September 30, 2025 | 337.90M |
| June 30, 2025 | 357.67M |
| March 31, 2025 | 378.80M |
| December 31, 2024 | 407.98M |
| September 30, 2024 | 430.87M |
| June 30, 2024 | 453.18M |
| March 31, 2024 | 473.65M |
| December 31, 2023 | 273.28M |
| September 30, 2023 | 296.82M |
| June 30, 2023 | 317.98M |
| March 31, 2023 | 346.65M |
| Date | Value |
|---|---|
| December 31, 2022 | 372.21M |
| September 30, 2022 | 399.26M |
| June 30, 2022 | 421.04M |
| March 31, 2022 | 228.71M |
| December 31, 2021 | 250.97M |
| September 30, 2021 | 270.01M |
| June 30, 2021 | 288.38M |
| March 31, 2021 | 305.99M |
| December 31, 2020 | 321.22M |
| September 30, 2020 | 334.98M |
| June 30, 2020 | -24.07M |
| March 31, 2020 | 26.12M |
| December 31, 2019 | -25.48M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | -161.84M |
| Theriva Biologics, Inc. | 12.19M |
| Unicycive Therapeutics, Inc. | 53.27M |
| OnKure Therapeutics, Inc. | 172.11M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 337.64M |
| Total Liabilities (Quarterly) | 89.91M |
| Debt to Equity Ratio | 0.2968 |
| Current Ratio | 7.981 |
| Net Debt Paydown Yield | 0.53% |